Cytarabine (Hospira, Inc.)


Welcome to the PulseAid listing for the Cytarabine drug offered from Hospira, Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: CYTARABINE
SUBSTANCE NAME: CYTARABINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
ROUTE: INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 1999-11-22
END MARKETING DATE: 0000-00-00


Cytarabine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCytarabine from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/mL)
START MARKETING DATE: 1999-11-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 61703-319_65f71161-db35-457d-8789-7f30832adbf9
PRODUCT NDC: 61703-319
APPLICATION NUMBER: ANDA075383

Other CYTARABINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Fresenius Kabi USA, LLCCytarabine
Hospira Worldwide, Inc.Cytarabine
Hospira, Inc.CYTARABINE
Mylan Institutional LLCCytarabine
Pfizer Laboratories Div Pfizer Inc.Cytarabine
Sigma-Tau Pharmaceuticals, Inc.DepoCyt